Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Upgrade now.
Date Value
September 30, 2024 6.867B
June 30, 2024 8.488B
March 31, 2024 8.523B
December 31, 2023 8.604B
September 30, 2023 7.573B
June 30, 2023 8.459B
March 31, 2023 8.923B
December 31, 2022 9.902B
September 30, 2022 8.348B
June 30, 2022 7.897B
March 31, 2022 10.12B
December 31, 2021 10.73B
September 30, 2021 8.906B
Date Value
June 30, 2021 7.99B
March 31, 2021 7.735B
December 31, 2020 4.608B
September 30, 2020 3.276B
June 30, 2020 2.717B
March 31, 2020 1.218B
December 31, 2019 1.103B
September 30, 2019 1.059B
June 30, 2019 1.070B
March 31, 2019 1.109B
December 31, 2018 1.521B
September 30, 2018 1.072B
December 31, 2017 756.03M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

1.103B
Minimum
Dec 2019
10.73B
Maximum
Dec 2021
7.099B
Average
8.169B
Median

Cash and Short Term Investments (Quarterly) Benchmarks

Eli Lilly and Co 3.518B
Merck & Co Inc 14.59B
Pfizer Inc 9.952B
Novavax Inc 909.53M
Biogen Inc 1.699B